La trimétazidine – nouvelle étiologie de troubles extrapyramidaux : un cas de syndrome parkinsonien avec akathisie
Thérapie, 60 6 (2005) 603-605
Published online: 2007-03-01
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Neurochemical aspects of the cardiotropic compound ALM-802S pharmacological activity
I. B. Tsorin, L. G. Kolik, M. B. Vititnova, V. V. Barchukov, G. V. Mokrov, V. S. Kudrin and S. A. KryzhanovskyPharmacokinetics and Pharmacodynamics (3) 39 (2025)
https://doi.org/10.37489/2587-7836-2025-3-39-46
A rare case of facio-bucco-linguo-masticatory dyskinesia induced by trimetazidine
Lei Yin, Zhaochao Liu, Yuxia Li, Zhenglong Luo, Zhong Xu and Xinglong YangActa Neurologica Belgica 123 (6) 2401 (2023)
https://doi.org/10.1007/s13760-023-02220-2
(2022)
https://doi.org/10.1101/2022.05.09.22274810
Trimetazidine Use in Parkinson’s Disease: Is It a Resolved Problem?
Dávid Pintér, Dániel Bereczki, András Ajtay, Ferenc Oberfrank, József Janszky and Norbert Kovácseneuro 8 (3) ENEURO.0452-20.2021 (2021)
https://doi.org/10.1523/ENEURO.0452-20.2021
The Impact of Trimetazidine on Disease Severity and Quality of Life in Parkinson’s Disease
Dávid Pintér, Annamária Juhász, Márk Harmat, József Janszky and Norbert KovácsScientific Reports 10 (1) (2020)
https://doi.org/10.1038/s41598-020-66692-5
Trimetazidine and parkinsonism: A prospective study
Dávid Pintér, Márton Kovács, Márk Harmat, Annamária Juhász, József Janszky and Norbert KovácsParkinsonism & Related Disorders 62 117 (2019)
https://doi.org/10.1016/j.parkreldis.2019.01.005
Drug-induced parkinsonism
José López-Sendón, Maria A Mena and Justo G de YébenesExpert Opinion on Drug Safety 12 (4) 487 (2013)
https://doi.org/10.1517/14740338.2013.787065
Extrapyramidal adverse drug reactions associated with trimetazidine: a series of 21 cases
Kamel Masmoudi, Henri Masson, Valérie Gras and Michel AndréjakFundamental & Clinical Pharmacology 26 (2) 198 (2012)
https://doi.org/10.1111/j.1472-8206.2011.01008.x
99 (2011)
https://doi.org/10.1017/CBO9780511920936.007
Encéphalopathie avec mouvements choréiformes induits par la trimétazidine : à propos d’un cas
J. Sivet, B. de la Gastine, B. Mosquet, et al.La Revue de Médecine Interne 29 (6) 512 (2008)
https://doi.org/10.1016/j.revmed.2007.12.001
Drug-induced parkinsonism
Maria A Mena and Justo G de YébenesExpert Opinion on Drug Safety 5 (6) 759 (2006)
https://doi.org/10.1517/14740338.5.6.759